Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection

Human Immunology

Volumn 70, Issue 12, 2009, Pages 1016-1019

  LeBouder, Fanny ^a   Khoufache, Khaled ^a   Menier, Catherine ^b,c   Mandouri, Yassmina ^a   Keffous, Mahmoud ^a   Lejal, Nathalie ^a   Krawice Radanne, Irène ^b,c   Carosella, Edgardo D ^b,c   Rouas Freiss, Nathalie ^b,c   Riteau, Béatrice ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b DIF   (France)

^c UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

Flu; HLA G; Immune escape; Influenza; Virus

Indexed keywords

HLA G ANTIGEN; MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; PROTEIN; TUBULIN;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS A; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; STRAIN DIFFERENCE; UPREGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CELL LINE; DOGS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; INFLUENZA A VIRUS; INFLUENZA, HUMAN; PULMONARY ALVEOLI; RESPIRATORY MUCOSA; RNA, MESSENGER; UP-REGULATION;

EID: 70449519161     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.07.026     Document Type: Article

References (43)

1. de Jong M.D., Simmons C.O., Thanh T.T., Hien V.N., Smith G.J., Chau T.N., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12 (2006) 1203-1207
2. Palese P. Influenza: Old and new threats. Nat Med 10 (2004) S82-S87
3. Webster R.G., and Govorkova E.A. H5N1 influenza-continuing evolution and spread. N Engl J Med 355 (2006) 2174-2177
4. Rimmelzwaan G.F., Fouchier R.A., and Osterhaus A.D. Influenza virus-specific cytotoxic T lymphocytes: A correlate of protection and a basis for vaccine development. Curr Opin Biotechnol 18 (2007) 529-536
5. Le Gal F.A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11 (1999) 1351-1356
6. Orvedahl A., and Levine B. Viral evasion of autophagy. Autophagy 4 (2008) 280-285
7. Carosella E.D., Moreau P., Lemaoult J., and Rouas-Freiss N. HLA-G: From biology to clinical benefits. Trends Immunol 29 (2008) 125-132
8. Riteau B., Menier C., Khalil-Daher I., Martinozzi S., Pla M., Dausset J., et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 13 (2001) 193-201
9. Riteau B., Menier C., Khalil-Daher I., Sedlik C., Dausset J., Rouas-Freiss N., and Carosella E.D. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 43 (1999) 203-211
10. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., and Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166 (2001) 5018-5026
11. Rouas-Freiss N., Khalil-Daher I., Riteau B., Menier C., Paul P., Dausset J., and Carosella E.D. The immunotolerance role of HLA-G. Semin Cancer Biol 9 (1999) 3-12
12. Menier C., Riteau B., Dausset J., Carosella E.D., and Rouas-Freiss N. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol 11 (2000) 1118-1125
13. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset D., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 94 (1997) 11520-11525
14. Gazit E., Sherf M., Balbin E., Muratov A., Goldstein I., and Loewenthal R. HLA-G expression is induced in Epstein-Barr virus-transformed B-cell lines by culture conditions. Hum Immunol 68 (2007) 463-468
15. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 79 (2005) 15226-15237
16. Megret F., Prehaud C., Lafage M., Moreau P., Rouas-Freiss N., Carosella E.D., and Lafon M. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum Immunol 68 (2007) 294-302
17. Lozano J.M., Gonzalez R., Kindelan J.M., Rouas-Freiss N., Caballos R., Dausset J., et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16 (2002) 347-351
18. Khoufache K., LeBouder F., Morello E., Laurent F., Riffault S., Andrade-Gordon P., et al. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol 182 (2009) 7795-7802
19. Riteau B., Faure F., Menier C., Viel S., Carosella E.D., Amigorena S., and Rouas-Freiss N. Exosomes bearing HLA-G are released by melanoma cells. Hum Immunol 64 (2003) 1064-1072
20. LeBouder F., Morello E., Rimmelzwaan G.F., Bosse F., Pechoux C., Delmas B., and Riteau B. Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol 82 (2008) 6820-6828
21. Rage F., Riteau B., Alonso G., and Tapia-Arancibia L. Brain-derived neurotrophic factor and neurotrophin-3 enhance somatostatin gene expression through a likely direct effect on hypothalamic somatostatin neurons. Endocrinology 140 (1999) 909-916
22. Moreau P., Mouillot G., Rousseau P., Marcou C., Dausset J., and Carosella E.D. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci U S A 100 (2003) 1191-1196
23. Bernard D., Riteau B., Hansen J.D., Phillips R.B., Michel F., Boudinot P., and Benmansour A. Costimulatory receptors in a teleost fish: Typical CD28, elusive CTLA4. J Immunol 176 (2006) 4191-4200
24. Riteau B., Barber D.F., and Long E.O. Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med 198 (2003) 469-474
25. Menier C., Guillard C., Cassinat B., Carosella E.D., and Rouas-Freiss N. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: Clinical relevance in polycythemia vera. Leukemia 22 (2008) 578-584
26. Riteau B., Moreau P., Menier C., Khalil-Daher I., Khosrotehrani K., Bras-Goncalves R., et al. Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line. Transplant Proc 33 (2001) 2360-2364
27. Pascale F., Contreras V., Bonneau M., Courbet A., Chilmonczyk S., Bevilacqua C., Eparaud M., et al. Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol 180 (2008) 5963-5972
28. Riteau B., de Vaureix C., and Lefevre F. Trypsin increases pseudorabies virus production through activation of the ERK signalling pathway. J Gen Virol 87 (2006) 1109-1112
29. Chang C.C., Murphy S.P., and Ferrone S. Differential in vivo and in vitro HLA-G expression in melanoma cells: Potential mechanisms. Hum Immunol 64 (2003) 1057-1063
30. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., and Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164 (2000) 6426-6434
31. Menier C., Riteau B., Carosella E.D., and Rouas-Freiss N. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. Int J Cancer 100 (2002) 63-70
32. Khalil-Daher I., Riteau B., Menier C., Sedlik C., Paul P., Dausset J., et al. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol 43 (1999) 175-182
33. Liang S., Baibakov B., and Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 32 (2002) 2418-2426
34. Liang S., Ristich V., Arase H., Dausset J., Carosella E.D., and Horuzsko A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci U S A 105 (2008) 8357-8362
35. Le Rond S., Azema C., Krawice-Radanne I., Durrbach A., Guettier C., Carosella E.D., and Rouas-Freiss N. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol 176 (2006) 3266-3276
36. Naji A., Le Rond S., Durrbach A., Krawice-Radanne I., Creput C., Daouya M., et al. CD3+CD4low and CD3+CD8low are induced by HLA-G: Novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 110 (2007) 3936-3948
37. Banham A.H., Colonna M., Cella M., Micklem K.J., Pulford K., Willis A.C., and Mason D.Y. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily. J Leukoc Biol 65 (1999) 841-845
38. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160 (1998) 3096-3100
39. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 (1999) 1093-1100
40. Seliger B., and Schlaf G. Structure, expression and function of HLA-G in renal cell carcinoma. Semin Cancer Biol 17 (2007) 444-450
41. Garcia-Sastre A. Antiviral response in pandemic influenza viruses. Emerg Infect Dis 12 (2006) 44-47
42. Hale B.G., Randall R.E., Ortin J., and Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89 (2008) 2359-2376
43. Steel J., Lowen A.C., Pena L., Angel M., Solorzano A., Albrecht R., et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 83 (2009) 1742-1753